Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVMD Revolution Medicines, Inc.

休市中 11-15 16:00:00 EST

55.13

-2.24

-3.90%

盘后55.13

+0.000.00%

19:06 EST

最高57.18	最低54.89	成交量194.43万
今开56.97	昨收57.37	日振幅3.99%
总市值92.74亿	流通市值85.34亿	总股本1.68亿
成交额1.08亿	换手率1.26%	流通股本1.55亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVMD","market":"US","secType":"STK","nameCN":"Revolution Medicines, Inc.","latestPrice":55.13,"timestamp":1731704400000,"preClose":57.37,"halted":0,"volume":1944303,"hourTrading":{"tag":"盘后","latestPrice":55.13,"preClose":55.13,"latestTime":"19:06 EST","volume":154015,"amount":8490836.18,"timestamp":1731715570239},"delay":0,"floatShares":154800378,"shares":168219391,"eps":-3.556464,"marketStatus":"休市中","marketStatusCode":7,"change":-2.24,"latestTime":"11-15 16:00:00 EST","open":56.97,"high":57.18,"low":54.89,"amount":107779747.833951,"amplitude":0.039916,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.556464,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1731920400000},"adr":0,"listingDate":1581570000000,"adjPreClose":57.37,"preHourTrading":{"tag":"盘前","latestPrice":56.97,"preClose":57.37,"latestTime":"09:29 EST","volume":518,"amount":29669.000116000003,"timestamp":1731680999994},"postHourTrading":{"tag":"盘后","latestPrice":55.13,"preClose":55.13,"latestTime":"19:06 EST","volume":154015,"amount":8490836.18,"timestamp":1731715570239},"volumeRatio":1.3451044374925472,"impliedVol":0.7677,"impliedVolPercentile":0.7976},"requestUrl":"/m/hq/s/RVMD","defaultTab":"news","newsList":[{"id":"2483439309","title":"Revolution Medicines, Inc.2024财年第三财季实现净利润-1.56亿美元，同比减少44.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483439309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483439309?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686420,"startTime":"0","endTime":"0","summary":"11月16日，Revolution Medicines, Inc.公布财报，公告显示公司2024财年第三财季净利润为-1.56亿美元，同比减少44.44%；其中营业收入为0.00美元，每股基本收益为-0.94美元。从资产负债表来看，Revolution Medicines, Inc.总负债1.97亿美元，其中短期债务8.40百万美元，资产负债比为8.95，流动比率为14.23。机构评级：截至2024年11月16日，当前有14家机构对Revolution Medicines, Inc.目标价做出预测，其中目标均价为71.43美元，其中最低目标价为63.00美元，最高目标价为86.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000047abc513a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000047abc513a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD"],"gpt_icon":0},{"id":"2483381214","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌7.71%报0.508美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483381214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483381214?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:50","pubTimestamp":1731603001,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日00时50分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速跳水7.71%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.59%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111500500195be2e0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111500500195be2e0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2483037378","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 下午盘快速下跌8.93%报0.556美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483037378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483037378?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:21","pubTimestamp":1731435664,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日02时21分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价急速跳水8.93%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.85%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113022105971a618d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113022105971a618d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMDW","RVMD"],"gpt_icon":0},{"id":"2482873764","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌7.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482873764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482873764?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:30","pubTimestamp":1731342601,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日00时30分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速下跌7.89%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.04%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111200300195be11fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111200300195be11fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMDW","RVMD"],"gpt_icon":0},{"id":"2481104883","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌9.23%报0.590美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481104883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481104883?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076369,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价快速下跌9.23%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.42%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324995bdef39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822324995bdef39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","BK4139","RVMD"],"gpt_icon":0},{"id":"2481213834","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大涨6.06%报0.700美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481213834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481213834?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:07","pubTimestamp":1730995655,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日00时07分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价快速拉升6.06%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.08%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108000736a2211fcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108000736a2211fcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD","RVMDW"],"gpt_icon":0},{"id":"2481184537","title":"Revolution Medicines Inc 报告截至 1 月 1 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2481184537","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481184537?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:09","pubTimestamp":1730992160,"startTime":"0","endTime":"0","summary":"Revolution Medicines Inc 报告截至 1 月 1 日的季度业绩 - 收益摘要Revolution Medicines Inc RVMD.OQ报告了截至1月1日的季度调整后每股亏损94美分，高于去年同期的每股-99美分。报告收入为零；分析师预期为 321,43,000 美元。Revolution Medicines Inc 公布的本季度每股收益为亏损 94 美分。该公司当季亏损 1.5629 亿美元。Revolution Medicines Inc 的股价本季度上涨了 31.0%，今年迄今为止上涨了 107.2%。华尔街对 Revolution Medicines Inc 的 12 个月目标价中位数为 70.00 美元。本摘要由 LSEG 11 月 7 日 03:08 p.m. UTC 调制解调器器生成。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4T3ME24H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RVMD"],"gpt_icon":0},{"id":"2481985734","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 急速拉升27.05%报0.762美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481985734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481985734?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903562,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价急速拉升27.05%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.49%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622324398e40dca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622324398e40dca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMDW","RVMD"],"gpt_icon":0},{"id":"2481685133","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 急速拉升8.57%报0.380美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481685133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481685133?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:59","pubTimestamp":1730818740,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时59分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速拉升8.57%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.77%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522590095bdd2b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522590095bdd2b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMDW","RVMD"],"gpt_icon":0},{"id":"2480058764","title":"Revolution Medicines, Inc.盘中异动 股价大涨5.07%报53.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480058764?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:05","pubTimestamp":1730390748,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日00时05分，Revolution Medicines, Inc.股票出现异动，股价快速上涨5.07%。截至发稿，该股报53.06美元/股，成交量73.0235万股，换手率0.44%，振幅5.74%。Revolution Medicines, Inc.股票所在的生物技术行业中，整体跌幅为3.44%。Revolution Medicines, Inc.公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101000548971a39af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101000548971a39af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2479303278","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘股价大涨29.85%报0.169美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479303278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479303278?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:25","pubTimestamp":1730388323,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时25分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价快速拉升29.85%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为3.47%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031232523a202a45c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031232523a202a45c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","RVMDW","BK4139"],"gpt_icon":0},{"id":"2479284881","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 大幅拉升5.17%报0.116美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479284881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479284881?lang=zh_cn&edition=full","pubTime":"2024-10-29 22:41","pubTimestamp":1730212902,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日22时41分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价大幅拉升5.17%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.05%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029224142971a2f64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029224142971a2f64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMDW","RVMD"],"gpt_icon":0},{"id":"2478840224","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘急速上涨8.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478840224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478840224?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:10","pubTimestamp":1730124603,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时10分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速拉升8.72%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.48%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822100395bd75f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102822100395bd75f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2477963250","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘快速跳水5.21%报0.122美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477963250","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477963250?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:01","pubTimestamp":1729778498,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时01分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价大幅下跌5.21%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.63%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422013898e3e427&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422013898e3e427&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD","RVMDW"],"gpt_icon":0},{"id":"2477552836","title":"Revolution Medicines, Inc.盘中异动 股价大涨5.27%报49.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477552836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477552836?lang=zh_cn&edition=full","pubTime":"2024-10-24 01:48","pubTimestamp":1729705693,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日01时48分，Revolution Medicines, Inc.股票出现异动，股价急速拉升5.27%。截至发稿，该股报49.61美元/股，成交量125.314万股，换手率0.75%，振幅7.36%。Revolution Medicines, Inc.股票所在的生物技术行业中，整体跌幅为1.18%。Revolution Medicines, Inc.公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024014813a1e487e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024014813a1e487e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2477533878","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫35.77% 市值跌5307.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477533878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477533878?lang=zh_cn&edition=full","pubTime":"2024-10-23 21:31","pubTimestamp":1729690311,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日21时31分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价急速下跌35.77%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.17%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321315195bd42c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102321315195bd42c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","RVMD","BK4139"],"gpt_icon":0},{"id":"2477411891","title":"Revolution Medicines, Inc.盘中异动 下午盘股价大跌5.02%报47.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477411891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477411891?lang=zh_cn&edition=full","pubTime":"2024-10-22 01:45","pubTimestamp":1729532717,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日01时45分，Revolution Medicines, Inc.股票出现波动，股价急速下跌5.02%。Revolution Medicines, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Revolution Medicines, Inc.公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022014518971a16c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022014518971a16c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD"],"gpt_icon":0},{"id":"2477865683","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价拉升38.61% 市值涨7660.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477865683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477865683?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:32","pubTimestamp":1729517524,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时32分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价快速上涨38.61%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.23%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121320495b8ccf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121320495b8ccf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","RVMDW","BK4139"],"gpt_icon":0},{"id":"2476207481","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌23.67%报0.109美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476207481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476207481?lang=zh_cn&edition=full","pubTime":"2024-10-17 21:37","pubTimestamp":1729172222,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日21时37分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价快速下跌23.67%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.27%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172137029f4a8826&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410172137029f4a8826&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2475099222","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘大幅上涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475099222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475099222?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:31","pubTimestamp":1729085463,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时31分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速上涨5.60%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.34%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621310398e3cc20&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101621310398e3cc20&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD","RVMDW"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revmed.com","stockEarnings":[{"period":"1week","weight":-0.0879},{"period":"1month","weight":0.0934},{"period":"3month","weight":0.2866},{"period":"6month","weight":0.3989},{"period":"1year","weight":1.5944},{"period":"ytd","weight":0.9222}],"compareEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.1063},{"period":"1year","weight":0.301},{"period":"ytd","weight":0.2324}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revolution Medicines, Inc.成立于2014年10月，是特拉华州的一家公司。该公司是一家临床阶段的精准肿瘤学公司，专注于开发靶向疗法，以抑制RAS成瘾癌症的前沿靶点。该公司拥有先进的基于结构的药物发现能力，其基础是深厚的化学生物学和癌症药理学知识以及创新的专有技术，能够创造适合非常规结合位点的小分子。该公司对癌症的遗传驱动因素和适应性耐药机制的了解，加上强大的药物发现和药物化学能力，指导建立了一个针对RAS通路和相关通路中的关键信号节点的深层管道。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.002389},{"month":2,"riseRate":0.75,"avgChangeRate":0.00657},{"month":3,"riseRate":0.6,"avgChangeRate":-0.008788},{"month":4,"riseRate":0.6,"avgChangeRate":0.034923},{"month":5,"riseRate":0.4,"avgChangeRate":-0.035334},{"month":6,"riseRate":1,"avgChangeRate":0.06444},{"month":7,"riseRate":0.4,"avgChangeRate":-0.00346},{"month":8,"riseRate":0.6,"avgChangeRate":0.068181},{"month":9,"riseRate":0.4,"avgChangeRate":-0.000203},{"month":10,"riseRate":0.6,"avgChangeRate":-0.028053},{"month":11,"riseRate":0.8,"avgChangeRate":0.15163},{"month":12,"riseRate":0.5,"avgChangeRate":0.014112}],"exchange":"NASDAQ","name":"Revolution Medicines, Inc.","nameEN":"Revolution Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revolution Medicines, Inc.,RVMD,Revolution Medicines, Inc.股票,Revolution Medicines, Inc.股票老虎,Revolution Medicines, Inc.股票老虎国际,Revolution Medicines, Inc.行情,Revolution Medicines, Inc.股票行情,Revolution Medicines, Inc.股价,Revolution Medicines, Inc.股市,Revolution Medicines, Inc.股票价格,Revolution Medicines, Inc.股票交易,Revolution Medicines, Inc.股票购买,Revolution Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}